Curevac N.V. (NQ: CVAC )

102.66 +5.53 (+5.69%)

Official Closing Price Updated: 7:57 PM EST, Dec 2, 2020 Add to My Watchlist

Price and Volume

Volume	514,498
Open	97.00
Bid (Size)	102.38 (1)
Ask (Size)	102.95 (9)
Prev. Close	97.13
Today's Range	96.90 - 103.41
52wk Range	36.15 - 106.50
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

CureVac Announces Financial Results and Business Updates for the Third Quarter and First Nine Months of 2020

November 30, 2020

CureVac to Report Third Quarter and First Nine Months 2020 Financial Results and Business Updates on November 30, 2020

November 26, 2020

Performance

YTD	+83.65%	+83.65%
1 Month	+118.05%	+118.05%
3 Month	+75.61%	+75.61%
6 Month	+83.65%	+83.65%
1 Year	+83.65%	+83.65%

More News

CureVac Establishes European-Based Network to Ramp Up Manufacturing of its COVID-19 Vaccine Candidate, CVnCoV

November 17, 2020

COVID Vaccine Stocks Update: Where Things Stand Now

Today 6:08 EST

Is Inovio Pharmaceuticals a Buy?

December 01, 2020

CureVac (CVAC) Q3 2020 Earnings Call Transcript

November 30, 2020

EU strikes deal with Moderna to supply up to 160 million vaccine shots

November 24, 2020

Pfizer, Moderna COVID-19 Vaccines Could Get Limited EU Approval Before Year-End: Report

November 20, 2020

This Under-the-Radar COVID Vaccine Stock Has a Tesla Tie-In

November 27, 2020

Maravai IPO: What Investors Should Know About Pfizer/BioNTech COVID-19 Vaccine Partner

November 19, 2020

Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday

November 20, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.